印度锡金邦2018-2019年全邦多年龄组HPV疫苗引入最佳实践
印度锡金邦于2018年通过以学校为基础的接种方式为9-13岁女孩引入HPV疫苗,目标约25000名女孩。2019年开展引入后评估,访谈279人并观察29次,行政数据显示两剂次HPV疫苗覆盖率均超过95%,未报告严重不良事件,利益相关方接受度高。
要点
- 锡金邦通过两轮 campaign 实现目标女孩两剂次HPV疫苗覆盖率均>95%。
- 无严重不良事件报告,利益相关方接受度高,拒绝接种极少。
- 成功因素包括政治承诺、全邦强制入学、卫生与教育部门协作及社会动员。
核心结论
- 锡金邦通过学校为基础的接种方式成功为多年龄组女孩引入HPV疫苗,可作为印度其他地区或类似中低收入国家的可复制模式。
研究设计与样本
- 2019年开展引入后评估,与第二剂次接种活动同期进行。
- 访谈关键利益相关者并审查规划文件,在锡金邦四个区各目的性抽取两个社区区域观察冷链站点。
- 使用标准化问卷访谈卫生和教育官员、学校人员、卫生工作者、社区领袖及适龄女孩。
- 共完成279次访谈和29次观察,覆盖四个区八个社区区域。
主要发现
- 基于报告的行政数据,锡金邦通过两轮活动实现目标女孩两剂次HPV疫苗覆盖率均>95%。
- 未报告严重不良事件。
- HPV疫苗被所有利益相关方良好接受,报告极少的拒绝接种。
关键数值与推荐
- 目标人群为9-13岁女孩,主要接种方式为学校为基础接种。
- 目标约25000名女孩。
- 两剂次HPV疫苗覆盖率均>95%(基于报告行政数据)。
临床怎么用
- 可借鉴锡金邦经验:强化政治承诺、利用全邦强制入学政策、促进卫生与教育部门各级协作、实施稳健社会动员策略。
- 在学校为基础接种中关注冷链管理及利益相关方沟通以提高接受度。
局限性
- 评估基于报告的行政数据和定性访谈观察,未报告覆盖率数据的独立验证方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cervical cancer is a leading cause of cancer-associated mortality among women in India, with 96,922 new cases and 60,078 deaths each year, almost one-fifth of the global burden. In 2018, Sikkim state in India introduced human papillomavirus (HPV) vaccine for 9-13-year-old girls, primarily through school-based vaccination, targeting approximately 25,000 girls. We documented the program's decision-making and implementation processes. METHODS: We conducted a post-introduction evaluation in 2019, concurrent with the second dose campaign, by interviewing key stakeholders (state, district, and local level), reviewing planning documents, and observing cold chain sites in two purposefully-sampled community areas in each of the four districts of Sikkim. Using standard questionnaires, we interviewed health and education officials, school personnel, health workers, community leaders, and age-eligible girls on program decision-making, planning, training, vaccine delivery, logistics, and communication. RESULTS: We conducted 279 interviews and 29 observations in eight community areas across four districts of Sikkim. Based on reported administrative data, Sikkim achieved >95% HPV vaccination coverage among targeted girls for both doses via two campaigns; no severe adverse events were reported. HPV vaccination was well accepted by all stakeholders; minimal refusal was reported. Factors identified for successful vaccine introduction included strong political commitment, statewide mandatory school enrollment, collaboration between health and education departments at all levels, and robust social mobilization strategies. CONCLUSIONS: Sikkim successfully introduced the HPV vaccine to multiple-age cohorts of girls via school-based vaccination, demonstrating a model that could be replicated in other regions in India or similar low- and middle-income country settings.
引用
- Ahmed D, VanderEnde K, Harvey P, et al. Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019. Vaccine. 2021. PMID: 34429233. doi:10.1016/j.vaccine.2021.07.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。